Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement for QuickStrip™ Oral Thin Strips

World News: . []

VANCOUVER, British Columbia, Oct. 12, 2018 (GLOBE NEWSWIRE) -- and (“”), a Canadian bio-technology company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes, are proud to announce they have signed a definitive agreement, providing a Managed Strip Service Agreement enabling Chemesis to produce QuickStrips™ infused with cannabis oils. 

RDT’s innovative QuickStrip is an easy-to-use, safe and effective oral fast-dissolving drug delivery system, developed in conjunction with McMaster University through the renowned Adronov Research Group, which provides accurate dosing and potency.  

Under the terms of the agreement, Chemesis will receive rights to produce, distribute and sell QuickStrip products, with rights for cannabis markets in California. With Chemesis’ state-of-the-art facility, the Company believes this partnership with RDT will further strengthen its position in the California cannabis market, by allowing the Company to use a convenient drug delivery system that can target a variety of consumers and also allow them to use cannabis products in a new way. The Company will continue to position itself to capitalize in this growing market with innovative and effective products.

“RDT is an innovator in the drug delivery world, making this an excellent opportunity for Chemesis,” said CEO of Chemesis, Edgar Montero. “QuickStrip is composed of therapeutic products and they also provide a drug delivery system that is quick, convenient, precise, discrete, convenient for travel, and an alternative for those who have problems swallowing pills. The Company believes it can use this drug delivery system to target a wide range of consumers and we look forward to distributing products in the near future.”

“RDT is pleased to be partnering with Chemesis to provide California’s consumers with a delivery method they can count on that begins the move away from inhalation for dosing therapeutic products,” explains Mark Upsdell, CEO of RDT.  “Chemesis has developed strategies, partnerships, quality oil production, and distribution channels that will allow QuickStrip to expand rapidly into the California market. We will work directly with Chemesis in developing additional white label partnerships with manufacturers and distributors in California.”

Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within Puerto Rico, and California.

Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution, and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods, to provide consumers with quality cannabis products.

Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently delivering quality product to its consumers from seed to sale.

More news and information about Chemesis International Inc.

Published By:

Globe Newswire: 09:00 GMT Friday 12th October 2018

Published: .

Search for other references to "chemesis" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us